These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14752027)

  • 21. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells.
    Kelley TJ; Elmer HL; Corey DA
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):732-8. PubMed ID: 11726399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta-induced differentiation of smooth muscle from a neural crest stem cell line.
    Chen S; Lechleider RJ
    Circ Res; 2004 May; 94(9):1195-202. PubMed ID: 15059931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation.
    Cheng PL; Chang MH; Chao CH; Lee YH
    Oncogene; 2004 Oct; 23(47):7821-38. PubMed ID: 15334054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
    Borton AJ; Frederick JP; Datto MB; Wang XF; Weinstein RS
    J Bone Miner Res; 2001 Oct; 16(10):1754-64. PubMed ID: 11585338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3.
    Stramer BM; Austin JS; Roberts AB; Fini ME
    J Cell Physiol; 2005 Apr; 203(1):226-32. PubMed ID: 15521071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
    Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
    J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
    Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceleration of palatal wound healing in Smad3-deficient mice.
    Jinno K; Takahashi T; Tsuchida K; Tanaka E; Moriyama K
    J Dent Res; 2009 Aug; 88(8):757-61. PubMed ID: 19734465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
    Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
    Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells.
    Gajewska M; Motyl T
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration-dependent bifunctional effect of TGF-beta 1 on immunoglobulin production: a role for Smad3 in IgA production in vitro.
    McKarns SC; Letterio JJ; Kaminski NE
    Int Immunopharmacol; 2003 Dec; 3(13-14):1761-74. PubMed ID: 14636827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor.
    Yamada M; Kim S; Egashira K; Takeya M; Ikeda T; Mimura O; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):1996-2001. PubMed ID: 14500291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of MCP-1/CCR2 signaling does not inhibit intimal proliferation in a mouse aortic transplant model.
    Alexis JD; Pyo RT; Chereshnev I; Katz J; Rollins BJ; Charo IF; Taubman MB
    J Vasc Res; 2008; 45(6):538-46. PubMed ID: 18463419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP.
    Dennler S; Pendaries V; Tacheau C; Costas MA; Mauviel A; Verrecchia F
    Oncogene; 2005 Mar; 24(11):1936-45. PubMed ID: 15688032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts.
    Kobayashi T; Liu X; Wen FQ; Fang Q; Abe S; Wang XQ; Hashimoto M; Shen L; Kawasaki S; Kim HJ; Kohyama T; Rennard SI
    Biochem Biophys Res Commun; 2005 Feb; 327(2):393-8. PubMed ID: 15629128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer.
    Han SU; Kim HT; Seong DH; Kim YS; Park YS; Bang YJ; Yang HK; Kim SJ
    Oncogene; 2004 Feb; 23(7):1333-41. PubMed ID: 14647420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.
    Yang X; Letterio JJ; Lechleider RJ; Chen L; Hayman R; Gu H; Roberts AB; Deng C
    EMBO J; 1999 Mar; 18(5):1280-91. PubMed ID: 10064594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3.
    Feinberg MW; Watanabe M; Lebedeva MA; Depina AS; Hanai J; Mammoto T; Frederick JP; Wang XF; Sukhatme VP; Jain MK
    J Biol Chem; 2004 Apr; 279(16):16388-93. PubMed ID: 14754879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis.
    Sakamoto T; Ueno H; Sonoda K; Hisatomi T; Shimizu K; Ohashi H; Inomata H
    Gene Ther; 2000 Nov; 7(22):1915-24. PubMed ID: 11127579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.